Ticker

No recent analyst price targets found for HHS.

Latest News for HHS

Harte Hanks Announces Expiration of "Go-Shop Period" and Designation of "Exempted Parties"

CHELMSFORD, MA / ACCESS Newswire / September 15, 2026 / Harte Hanks, Inc. ("Harte Hanks" or the "Company") announced today the expiration of the "Go-Shop Period" set forth in the previously announced Agreement and Plan of Merger with Star Equity Holdings, Inc. ("Star"), dated as of August 14, 2026 (the "Star Merger Agreement"), the receipt of "Acquisition Proposals" (as defined in the Star Merger Agreement), and the…

Accesswire • Sep 15, 2026
HHS plans new FDA deputy commissioner roles for technology and drugs, sources say

The Department of Health and Human Services is planning to appoint deputy commissioners for technology and drugs at the FDA, creating new roles at the agency, CNBC has learned. Like existing deputy commissioner roles, the two new positions would report into Trump's pick for FDA commissioner, Heidi Overton, who still needs to be confirmed by the Senate.

CNBC • Aug 25, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for HHS.

No House trades found for HHS.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top